BR

Bimla Rani

Director Director DIN 10981484
DIN 10981484 First appointment Mar 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2025
Shareholding value Locked Premium profile

About Bimla Rani

Bimla Rani has 1 years in corporate governance. Formerly with 1 company, such as Emfica Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10981484
Primary Designation Director
First Appointment 03 Mar 2025
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Emfica Pharmaceuticals Private Limited U21002HR2025PTC129221
Director 03 Mar 2025 2025 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emfica Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bimla Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bimla Rani

Bimla Rani has 1 years in corporate governance. Formerly with 1 company, such as Emfica Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Bimla Rani is associated with 0 companies as a director.

Bimla Rani has expertise in General Business.

Bimla Rani has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available